Tempus to buy cancer test maker Personalis for $1.5 billion - Reuters
Tempus to buy cancer test maker Personalis for $1.5 billion Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOeDdaUjUzN3pPOUFOZFZnRDQtelVrYUFKcDFGZUxMXzhxVFlQejhnSWJ2b2VkM2h0YnRfRXJ6Qm0tMFQ5eWNLZW4yRncwZXVvN2dZWFE4LS02WkRuS2JiblQ0U3VVSm9jaGs5TjdtNnhzLXFBMUNuYXlUd2o0OGxwd0kzaVc3UUZ5QUJBQmpfVFNOSkN3c0RKcktoekRBMFJENEFBa0JranFHSjJs?oc=5" target="_blank">Tempus to buy cancer test maker Personalis for $1.5 billion</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
'What terminal cancer has taught me about life'
A Gloucestershire man with terminal cancer shares the life lessons he wishes he'd learned sooner.
October 10, 2026 at 06:16 AMBoots has a new owner: Three ways it could affect you
The stalwart of Britain's High Street has been sold to a Canadian billionaire family. What will that mean for you?
October 9, 2026 at 11:01 PMReport highlights flaws in ADHD and autism care
There is a risk of people being over-diagnosed with ADHD and autism, an official review in England has found.
October 9, 2026 at 01:52 PMHumana surges after topping 2027 Medicare star ratings - Reuters
Humana surges after topping 2027 Medicare star ratings Reuters
October 9, 2026 at 01:33 PMMost Medicare Advantage drug plan enrollees in high-quality plans, US government says - Reuters
Most Medicare Advantage drug plan enrollees in high-quality plans, US government says Reuters
October 8, 2026 at 11:29 PMADHD and autism at risk of over-diagnosis, says government review
The review, which focuses on younger people, warned there was a risk society was moving from an era of under-diagnosis to over-diagnosis.
October 8, 2026 at 11:01 PM